Navigation Links
Align Technology Announces Fourth Quarter and Fiscal 2008 Results
Date:1/28/2009

Q4 08 U.S. Orthodontists 90.7% U.S. GP Dentists 86.0% International 77.4% Doctors Starting Invisalign Treatment (Cumulative as of): Q4 08 U.S. Orthodontists 7,140 U.S. GP Dentists 25,960 International 8,160 Total Doctors Starting Invisalign Treatment 41,260 Q4 08 Q3 08 Q4 07 Doctor Utilization Rates*: U.S. Orthodontists 4.6 4.8 4.8 U.S. GP Dentists 2.3 2.4 2.5 International 3.4 3.2 3.2 Total Utilization Rate 3.0 3.0 3.1 * Utilization = # of cases/# of doctors to whom cases were shipped

Business Outlook

Commenting on Align's business outlook, Kenneth Arola, vice president of finance and CFO said, "The economic environment and its impact on consumer spending has created greater uncertainty for our business. As a result, we are only providing guidance for Q1 09. The greatest uncertainties beyond Q1 involve case volume and revenues. We believe it will be very difficult to grow in this environment and are expecting revenues to decline from 2008. We will continue to invest in our key strategic growth initiatives and manage overall expenses to drive operating profitability for fiscal 2009."

For the first quarter of fiscal 2009 (Q1 09), Align Technology expects net revenues to be in a range of $65 million to $69 million. Operating margin for Q1 09 is expected to be in a range of -4% to 0%. GAAP earnings per diluted share for Q1 09 is expected to be in a range of a loss of $0.04 to breakeven. Non-G
'/>"/>

SOURCE Align Technology
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15

Related medicine news :

1. MedPredict Publishes Two New Reports Providing Expert Analysis of Malignant Hematology Drug Development
2. A Stage IV Malignant Melanoma Drug That Increases Overall Survival Would Earn a Higher Patient Share in the U.S. Than in Europe
3. Tennessee Hospital Association Selects PivotHealth To Provide Hospital-Physician Alignment Services
4. FDA Clears Expanded Labeling for the Invisalign System
5. Align Technology to Announce Fourth Quarter and Fiscal Year 2008 Results on January 28, 2009
6. Cardo Medical Announces FDA Clearance of the Align 360 Total Knee System
7. Align Technology Announces Third Quarter Fiscal 2008 Results
8. 5- and 10-year survival continues to improve for US children with hematologic malignancies
9. SpectraScience Awarded Patent for Correcting Image Misalignment
10. Align Technology Announces Second Quarter Fiscal 2008 Results
11. Align Technology Targets Mainstream Orthodontics Market With Invisalign Teen(TM)

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/26/2009)...le Dental (RTDental), a leading dental group pract... expansion of its services to include LUMINEERS by... , Durham, NC (PRWEB) ... that Dr. Doug Macmillan, an experienced LUMINEER...ced training seminar. RTDental’s ability to...
(Date:11/25/2009)...re-FirstCall/-- OnyxPharmaceuticals,Inc.(Nasdaq: ...toreventsinDecember: ,, ASHBriefing ,, ...ncipalinvestigatorswilldiscussdatapresentationssur...plemyeloma,asfeaturedatthe51stAmericanSocietyofHem...,LA.Theteleconferencewillbeginat9:00a.m.CT/10:00a....
(Date:11/25/2009)...wswire/--TheBlackAIDSInstituterecentlyheldBoardofD...010. ,, ThenewBoardMembersareahighlydiversegrou...e,governmenthealthprograms,editorial,andbusinessen...rsonalbackgroundsincludingbothheterosexualandgayBl...esentingmultipleagegroups. ,, (Photo: http://ww...
(Date:11/25/2009)...of a collaboration between UCLA engineers and phys...10 million Americans who suffer from peripheral ar... the arteries, peripheral arterial disease, or PAD...d arteries reduce blood flow to the limbs. The con...se, heart attack and stroke, and its progression c...
(Date:11/25/2009)... to overlook needed care, study finds , ,...s depression can worsen her child,s asthma, U.S. r...of 262 black mothers and their children found that...ms had more frequent asthma symptoms, while childr...ess frequent asthma symptoms. , The Johns Hopki...
Breaking Medicine News(10 mins):Health News:Dr. Douglas Macmillan Now Providing LUMINEERS at Research Triangle Dental 2Health News:Onyx Pharmaceuticals Announces December 2009 Investor Events 2Health News:Black AIDS Institute Announces 2010 Board Election Results 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 2Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 3Health News:Engineers, doctors at UCLA develop novel material that could help fight arterial disease 4Health News:Mom's Depression May Worsen Child's Asthma 2
...s been detected in Asia, the British government an...re sites for any evidence of bird flu. The dea...s, reservoirs and parks will be brought to the not... from the University of Hong Kong have detected a ...
...ptoms of schizophrenia can be relieved by music th... London conducted a study in 4 hospitals and found...ents when they were encouraged to express themselv...n people are fairly stable," said Dr Mike Crawford...
...today welcomed the Stern Review as a timely and au...mpact of climate change on the world’s human popul... now. Commissioned by the UK Government and p...ortant he has ever received. Dr Haikerwal sa...
...om umbilical cord blood stem cells for the first t...eed for animal experiments for drug testing. A...ize of a 1p coin, is just the initial phase of gen... association with experts from the U.S. The artifi...
...n's agency has launched the first online game in K... HIV and Aids. The game is named as "What woul...ough several different scenarios so that he import...Aids. Africa has the largest number of HIV inf...
...nfant’s risk of cot death or sudden infant death s...hat affect breathing and temperature control. // ...s who died of SIDS. The findings were published in...ocessing of the chemical called serotonin in the b...
Other Medicine News:Health News:A Timely Reminder Of Devastating Health Impact Of Climate Change 2Health News:Artificial Liver from Cord Blood Stem cells 2Health News:Brain stem Defects associated with SIDS 2
(Date:11/25/2009)...RIDGEWATER,N.J.,Nov.25/PRNewswire/--TheFDAgrantedt...blets,anon-nucleosidereversetranscriptaseinhibitor...edforuseintreatment-experiencedadultswhoareexperie...NNRTIandotherantiretroviral(ARV)agents.Thetraditio...sknownasDUET-1andDUET-2.INTELENCEiscurrentlymarket...
(Date:11/25/2009)...ASKINGRIDGE,N.J.,Nov.25/PRNewswire/--RegadoBioscie...ntithromboticaptamerswithactivecontrolagents,annou...ntingatthePiperJaffray21stAnnualHealthCareConferen...resentationwillbegivenat1:10pm(EST)onTuesday,Decem...withemphasisontheleaddevelopmentprogram,theanticoa...
(Date:11/25/2009)...NIONCITY,Calif.,Nov.25/PRNewswire-FirstCall/--Abax...facturingpoint-of-carebloodanalysissystems,announc...officer,willpresentatthe21stAnnualPiperJaffrayHeal...m.ET.TheconferencewillbeheldattheNewYorkPalaceHote...velops,manufacturesandmarketsportablebloodanalysis...
Breaking Medicine Technology:U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 2U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 3U.S. Food And Drug Administration (FDA) Grants Traditional Approval for INTELENCE(R) (etravirine) 4Regado Biosciences to Present at the Piper Jaffray 21st Annual Health Care Conference on December 1, 2009 2A WIT Technologies Releases World 26apos 3Bs First Low Cost C Stamp 28TM 29 Based Biotechnology Laboratory in a Box 12572 1A WIT Technologies Releases World 26apos 3Bs First Low Cost C Stamp 28TM 29 Based Biotechnology Laboratory in a Box 12572 2Polycom and AMD Global Telemedicine Inc To Deliver Integrated Visual And Voice Telehealth Capability To Clinicians On The Go 48554 1Polycom and AMD Global Telemedicine Inc To Deliver Integrated Visual And Voice Telehealth Capability To Clinicians On The Go 48554 2Polycom and AMD Global Telemedicine Inc To Deliver Integrated Visual And Voice Telehealth Capability To Clinicians On The Go 48554 3Want to Learn How to Testify 3F New Home Study Course by Practicing Physician Teaches Medical Malpractice Defendants and Physicians How to be Effectiv 48551 1Want to Learn How to Testify 3F New Home Study Course by Practicing Physician Teaches Medical Malpractice Defendants and Physicians How to be Effectiv 48551 2Want to Learn How to Testify 3F New Home Study Course by Practicing Physician Teaches Medical Malpractice Defendants and Physicians How to be Effectiv 48551 3
...6 D-Pharm announced today that it,has submitted I...to the US,Food and Drug Administration (FDA), for ...acute ischemic stroke patients. D-Pharm plans to i...view of the IND and SPA. Recently,D-Pharm also obt...s Agency,(EMEA) on the development strategy for DP...
...ikely to Suffer from Lower Body Injuries , , CINC..., obese children are significantly more likely to ...and legs. The Cincinnati Children,s Hospital Medic...if different body parts are injured in obese child...ion strategies can be developed, was presented May...
Other Medicine Technology:D-Pharm Submits Investigational New Drug Application and Special Protocol Assessment to the FDA for Phase III Trial of DP-b99 in Acute Stroke Patients 2D-Pharm Submits Investigational New Drug Application and Special Protocol Assessment to the FDA for Phase III Trial of DP-b99 in Acute Stroke Patients 3The Injured Obese Child: Let's Give Him Some Ankle Support 2The Injured Obese Child: Let's Give Him Some Ankle Support 3
...ctious disease ELISA products make us a leader in ...er integration into the busy laboratory, our Infec...iability and run-to-run consistency. Our Infectiou...ssays for a wide range of serological assays inclu...
...ctious disease ELISA products make us a leader in ...er integration into the busy laboratory, our Infec...iability and run-to-run consistency. Our Infectiou...ssays for a wide range of serological assays inclu...
...ctious disease ELISA products make us a leader in ...er integration into the busy laboratory, our Infec...iability and run-to-run consistency. Our Infectiou...ssays for a wide range of serological assays inclu...
...ctious disease ELISA products make us a leader in ...er integration into the busy laboratory, our Infec...iability and run-to-run consistency. Our Infectiou...ssays for a wide range of serological assays inclu...
Medicine Products: